Psychedelic drugs have shown promise for treating neuropsychiatric disorders such as depression and post-traumatic stress disorder.
However, due to their hallucinatory side effects, some researchers are trying to identify drugs that could offer the benefits of psychedelics without causing hallucinations.
In the journal Cell on April 28, researchers report they have identified one such drug through the development of a genetically encoded fluorescent sensor – called psychLight – that can screen for hallucinogenic potential by indicating when a compound activates the serotonin 2A receptor. [Read more…] about Researchers identify a psychedelic-like drug without the hallucinogenic side effects
Related Posts
- 34Serotonin is a neurochemical that plays a critical role in the way the brain controls our thoughts and feelings. For example, many antidepressants are designed to alter serotonin signals sent between neurons. In an article in Cell, National Institutes of Health-funded researchers described how they used advanced genetic engineering techniques to…